Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Medical University of South Carolina
mi
from
Charleston, SC
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
The Endocrine Clinic
mi
from
Memphis, TN
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
The Endocrine Clinic
mi
from
Memphis, TN
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Vanderbilt University
mi
from
Nashville, TN
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Ellen Sher, MD PA
mi
from
Dallas, TX
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Ellen Sher, MD PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Children's Medical Center
mi
from
Dallas, TX
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Children's Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Cooks Children Medical Center/Dept. of Pediatric Endocrinology
mi
from
Fort Worth, TX
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Cooks Children Medical Center/Dept. of Pediatric Endocrinology
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.
A Pilot Study of Pre- and Post-operative Somatuline Depot Therapy in Acromegalic Patients Treated by Endonasal Endoscopic Surgery: Impact on Early Remission Rates and Perioperative Morbidity
Status: Enrolling
Updated:  3/14/2016
Brain Tumor Center and Pituitary Disorders Program, John Wayne Cancer Institute, Saint John's Health System
mi
from
Santa Monica, CA
A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.
A Pilot Study of Pre- and Post-operative Somatuline Depot Therapy in Acromegalic Patients Treated by Endonasal Endoscopic Surgery: Impact on Early Remission Rates and Perioperative Morbidity
Status: Enrolling
Updated: 3/14/2016
Brain Tumor Center and Pituitary Disorders Program, John Wayne Cancer Institute, Saint John's Health System
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Pioglitazone for the Treatment of Bipolar Depression
Double-Blind, Placebo-Controlled Trial of Pioglitazone for Bipolar Depression
Status: Enrolling
Updated:  3/16/2016
University Hospitals Case Medical Center - Mood Disorders Program
mi
from
Cleveland, OH
Pioglitazone for the Treatment of Bipolar Depression
Double-Blind, Placebo-Controlled Trial of Pioglitazone for Bipolar Depression
Status: Enrolling
Updated: 3/16/2016
University Hospitals Case Medical Center - Mood Disorders Program
mi
from
Cleveland, OH
Click here to add this to my saved trials
7 Day Continuous Parathyroid Hormone IV Infusion
Determining the Maximal Safe Dose of a Continuous Infusion of Parathyroid Hormone(1-34): Effects on Bone Formation
Status: Enrolling
Updated:  3/18/2016
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
7 Day Continuous Parathyroid Hormone IV Infusion
Determining the Maximal Safe Dose of a Continuous Infusion of Parathyroid Hormone(1-34): Effects on Bone Formation
Status: Enrolling
Updated: 3/18/2016
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Pilot Study on Diurnal Variation
A Pilot Study on the Diurnal Variation in PKU Patients With Kuvan
Status: Enrolling
Updated:  3/21/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
A Pilot Study on Diurnal Variation
A Pilot Study on the Diurnal Variation in PKU Patients With Kuvan
Status: Enrolling
Updated: 3/21/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Effects of IGF-I in HIV Metabolic Disease
Effects of Recombinant IGF-I in HIV Associated Metabolic Disease
Status: Enrolling
Updated:  3/22/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Effects of IGF-I in HIV Metabolic Disease
Effects of Recombinant IGF-I in HIV Associated Metabolic Disease
Status: Enrolling
Updated: 3/22/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults
A Novel Therapy for Glucose Intolerance in HIV Disease
Status: Enrolling
Updated:  3/22/2016
State University of New York/General Clinical Research Center
mi
from
Stony Brook, NY
Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults
A Novel Therapy for Glucose Intolerance in HIV Disease
Status: Enrolling
Updated: 3/22/2016
State University of New York/General Clinical Research Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study
The Role of an Optical Probe in the Detection of Thyroid Cancer and Normal Thyroid Tissue in a Thyroidectomy Specimen: A Pilot Study
Status: Enrolling
Updated:  3/28/2016
Boston Med Ctr
mi
from
Boston, MA
The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study
The Role of an Optical Probe in the Detection of Thyroid Cancer and Normal Thyroid Tissue in a Thyroidectomy Specimen: A Pilot Study
Status: Enrolling
Updated: 3/28/2016
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Healthy Oils for Women (HOW Study)
Healthy Oils for Women: Reducing Visceral Adipose Tissue in Women With Metabolic Syndrome (HOW Study)
Status: Enrolling
Updated:  3/30/2016
The Ohio State University Exercise Physiology Lab
mi
from
Columbus, OH
Healthy Oils for Women (HOW Study)
Healthy Oils for Women: Reducing Visceral Adipose Tissue in Women With Metabolic Syndrome (HOW Study)
Status: Enrolling
Updated: 3/30/2016
The Ohio State University Exercise Physiology Lab
mi
from
Columbus, OH
Click here to add this to my saved trials
Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers
A Single Site, Randomized Open Label Cross-Over Study to Compare Pharmacokinetic Profiles (PK) of XueZhiKang (XZK) Capsules Versus Lovastatin Tablets in Healthy Male Volunteers
Status: Enrolling
Updated:  3/31/2016
NRC Research Institute
mi
from
Orange, CA
Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers
A Single Site, Randomized Open Label Cross-Over Study to Compare Pharmacokinetic Profiles (PK) of XueZhiKang (XZK) Capsules Versus Lovastatin Tablets in Healthy Male Volunteers
Status: Enrolling
Updated: 3/31/2016
NRC Research Institute
mi
from
Orange, CA
Click here to add this to my saved trials
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Status: Enrolling
Updated:  4/1/2016
Providence Medical Research Center
mi
from
Spokane, WA
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Status: Enrolling
Updated: 4/1/2016
Providence Medical Research Center
mi
from
Spokane, WA
Click here to add this to my saved trials
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Tucson, AZ
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Palo Alto, CA
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Wilmington, DE
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Wilmington, DE
Click here to add this to my saved trials
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Miami, FL
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Chicago, IL
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Boston, MA
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Buffalo, NY
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Manhasset, NY
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Manhasset, NY
Click here to add this to my saved trials
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
New York, NY
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Cincinnati, OH
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Philadelphia, PA
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
San Francisco, CA
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated:  4/5/2016
mi
from
Córdoba,
A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated: 4/5/2016
mi
from
Córdoba,
Click here to add this to my saved trials
The Effect of Blueberries on Enhancing Insulin Sensitivity in Humans: A Pilot Study
The Effect of Anthocyanins in the Form of Blueberry Powder on Enhancing Insulin Sensitivity in Insulin Resistant and Obese Humans
Status: Enrolling
Updated:  4/7/2016
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
The Effect of Blueberries on Enhancing Insulin Sensitivity in Humans: A Pilot Study
The Effect of Anthocyanins in the Form of Blueberry Powder on Enhancing Insulin Sensitivity in Insulin Resistant and Obese Humans
Status: Enrolling
Updated: 4/7/2016
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Effect of Dietary Flavonoids on Intestinal Microbiota, Intestinal Inflammation and Metabolic Syndrome
Effect of Dietary Flavonoids on Intestinal Microbiota, Intestinal Inflammation and Metabolic Syndrome
Status: Enrolling
Updated:  4/14/2016
Utah State University, Center for Human Nutrition Studies
mi
from
Logan, UT
Effect of Dietary Flavonoids on Intestinal Microbiota, Intestinal Inflammation and Metabolic Syndrome
Effect of Dietary Flavonoids on Intestinal Microbiota, Intestinal Inflammation and Metabolic Syndrome
Status: Enrolling
Updated: 4/14/2016
Utah State University, Center for Human Nutrition Studies
mi
from
Logan, UT
Click here to add this to my saved trials
Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults
Trace Elements and CVD Risk Factors Among Young Adults
Status: Enrolling
Updated:  4/15/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults
Trace Elements and CVD Risk Factors Among Young Adults
Status: Enrolling
Updated: 4/15/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Harbor UCLA Pediatrics
mi
from
Torrance, CA
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Harbor UCLA Pediatrics
mi
from
Torrance, CA
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Children's National Health System
mi
from
Washington,
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Children's National Health System
mi
from
Washington,
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Hospital Universitario Austral
mi
from
Pilar,
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Hospital Universitario Austral
mi
from
Pilar,
Click here to add this to my saved trials
Improving the STOP-Bang Screening Questionnaire for Patients With Sleep Apnea
Improving the Sensitivity and Specificity of the STOP-Bang Screening Questionnaire for Patients With Obstructive Sleep Apnea
Status: Enrolling
Updated:  4/20/2016
Sleep Center, Tufts Medical Center
mi
from
Boston, MA
Improving the STOP-Bang Screening Questionnaire for Patients With Sleep Apnea
Improving the Sensitivity and Specificity of the STOP-Bang Screening Questionnaire for Patients With Obstructive Sleep Apnea
Status: Enrolling
Updated: 4/20/2016
Sleep Center, Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Effects of Hi-maize Resistant Starch on Insulin Sensitivity
A Randomized, Controlled, Double-blind Crossover Study to Assess the Effects of a Dietary Fiber Ingredient, at Two Doses, on Insulin Sensitivity
Status: Enrolling
Updated:  4/20/2016
Provident Clinical Research and Consulting Inc
mi
from
Glen Ellyn, IL
Effects of Hi-maize Resistant Starch on Insulin Sensitivity
A Randomized, Controlled, Double-blind Crossover Study to Assess the Effects of a Dietary Fiber Ingredient, at Two Doses, on Insulin Sensitivity
Status: Enrolling
Updated: 4/20/2016
Provident Clinical Research and Consulting Inc
mi
from
Glen Ellyn, IL
Click here to add this to my saved trials
Aerobic Plus Resistance Training and Insulin Sensitivity in African American Men
Aerobic Plus Resistance Training and Insulin Sensitivity in African American Men
Status: Enrolling
Updated:  5/2/2016
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Aerobic Plus Resistance Training and Insulin Sensitivity in African American Men
Aerobic Plus Resistance Training and Insulin Sensitivity in African American Men
Status: Enrolling
Updated: 5/2/2016
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Nutritional Supplement Impact on Metabolic Parameters
An Open-Label Single-Center Study to Determine Safety and Effects of Novel Nutritional Blend on Inflammatory Balance Markers and Metabolic Parameters
Status: Enrolling
Updated:  5/2/2016
Texas Diabetes & Endocrinology, PA
mi
from
Austin, TX
Nutritional Supplement Impact on Metabolic Parameters
An Open-Label Single-Center Study to Determine Safety and Effects of Novel Nutritional Blend on Inflammatory Balance Markers and Metabolic Parameters
Status: Enrolling
Updated: 5/2/2016
Texas Diabetes & Endocrinology, PA
mi
from
Austin, TX
Click here to add this to my saved trials
Nutritional Supplement Impact on Metabolic Parameters
An Open-Label Single-Center Study to Determine Safety and Effects of Novel Nutritional Blend on Inflammatory Balance Markers and Metabolic Parameters
Status: Enrolling
Updated:  5/2/2016
Utah State University
mi
from
Logan, UT
Nutritional Supplement Impact on Metabolic Parameters
An Open-Label Single-Center Study to Determine Safety and Effects of Novel Nutritional Blend on Inflammatory Balance Markers and Metabolic Parameters
Status: Enrolling
Updated: 5/2/2016
Utah State University
mi
from
Logan, UT
Click here to add this to my saved trials
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
A Phase I, Multicenter, Open-label, Randomized Study Assessing the Pharmacokinetics, Safety, and Tolerability of Monthly Doses of Pasireotide i.m. LAR Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Status: Enrolling
Updated:  5/2/2016
Cedars Sinai Medical Center SC - 4
mi
from
Los Angeles, CA
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
A Phase I, Multicenter, Open-label, Randomized Study Assessing the Pharmacokinetics, Safety, and Tolerability of Monthly Doses of Pasireotide i.m. LAR Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Status: Enrolling
Updated: 5/2/2016
Cedars Sinai Medical Center SC - 4
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
A Phase I, Multicenter, Open-label, Randomized Study Assessing the Pharmacokinetics, Safety, and Tolerability of Monthly Doses of Pasireotide i.m. LAR Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Status: Enrolling
Updated:  5/2/2016
Stanford University Medical Center Stanford Cancer Center (3)
mi
from
Stanford, CA
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
A Phase I, Multicenter, Open-label, Randomized Study Assessing the Pharmacokinetics, Safety, and Tolerability of Monthly Doses of Pasireotide i.m. LAR Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Status: Enrolling
Updated: 5/2/2016
Stanford University Medical Center Stanford Cancer Center (3)
mi
from
Stanford, CA
Click here to add this to my saved trials
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
A Phase I, Multicenter, Open-label, Randomized Study Assessing the Pharmacokinetics, Safety, and Tolerability of Monthly Doses of Pasireotide i.m. LAR Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Status: Enrolling
Updated:  5/2/2016
H. Lee Moffitt Cancer Center & Research Institute Dept.of H.LeeMoffittCC&RI(1)
mi
from
Tampa, FL
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
A Phase I, Multicenter, Open-label, Randomized Study Assessing the Pharmacokinetics, Safety, and Tolerability of Monthly Doses of Pasireotide i.m. LAR Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Status: Enrolling
Updated: 5/2/2016
H. Lee Moffitt Cancer Center & Research Institute Dept.of H.LeeMoffittCC&RI(1)
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
A Phase I, Multicenter, Open-label, Randomized Study Assessing the Pharmacokinetics, Safety, and Tolerability of Monthly Doses of Pasireotide i.m. LAR Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Status: Enrolling
Updated:  5/2/2016
University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology
mi
from
Houston, TX
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
A Phase I, Multicenter, Open-label, Randomized Study Assessing the Pharmacokinetics, Safety, and Tolerability of Monthly Doses of Pasireotide i.m. LAR Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Status: Enrolling
Updated: 5/2/2016
University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
A Phase I, Multicenter, Open-label, Randomized Study Assessing the Pharmacokinetics, Safety, and Tolerability of Monthly Doses of Pasireotide i.m. LAR Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Status: Enrolling
Updated:  5/2/2016
Novartis Investigative Site
mi
from
Bruxelles,
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
A Phase I, Multicenter, Open-label, Randomized Study Assessing the Pharmacokinetics, Safety, and Tolerability of Monthly Doses of Pasireotide i.m. LAR Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Status: Enrolling
Updated: 5/2/2016
Novartis Investigative Site
mi
from
Bruxelles,
Click here to add this to my saved trials
The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study
The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study
Status: Enrolling
Updated:  5/18/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study
The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study
Status: Enrolling
Updated: 5/18/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Strict or Liberal Insulin Protocol Following Coronary Artery Bypass Graft (CABG) Surgery
Strict or Liberal Insulin Protocol Following Coronary Artery Bypass Graft (CABG) Surgery
Status: Enrolling
Updated:  5/24/2016
Inova Fairfax Hospital
mi
from
Falls Church, VA
Strict or Liberal Insulin Protocol Following Coronary Artery Bypass Graft (CABG) Surgery
Strict or Liberal Insulin Protocol Following Coronary Artery Bypass Graft (CABG) Surgery
Status: Enrolling
Updated: 5/24/2016
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials